Biovie (BIVI) Invested Capital (2016 - 2024)
Biovie (BIVI) recorded Invested Capital of $17.39 million in fiscal Q1 2025 (quarter ended Sep 30, 2024), down 12.4% from $19.86 million a year earlier and down 18.0% from the prior quarter.
Powered by 
Analysis
Biovie (BIVI) Invested Capital (2016 - 2024) Analysis & Trends
For FY2024 (ended Jun 30, 2024), Biovie reported Invested Capital of $21.21 million, down 28.5% from FY2023.
- Across earlier fiscal years, Invested Capital came in at $29.67 million in FY2023 (+87.7%), $15.81 million in FY2022 and -$21.44 million in FY2020.
- The fiscal Q1 2025 figure is the lowest quarterly Invested Capital since fiscal Q4 2022.
- On a year-over-year basis, Invested Capital has declined for four consecutive quarters, with growth averaging 10.4% over the last eight quarters.
- Peak year-over-year performance for Invested Capital in the last five years was growth of 106.9% in fiscal Q2 2022, against a decline of 55.0% in fiscal Q2 2024 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $21.21 million (Q4 2024), $26.92 million (Q3 2024) and $17.69 million (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 88.79 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 134.01 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 64.89 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 95.89 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 79.44 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 50.26 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 68.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 38.08 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 148.69 Bn |
| 10 | Biovie | 11.09 Mn | 11.09 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 17.39 Mn |
| Jun 30, 2024 | 21.21 Mn |
| Mar 31, 2024 | 26.92 Mn |
| Dec 31, 2023 | 17.69 Mn |
| Sep 30, 2023 | 19.86 Mn |
| Jun 30, 2023 | 29.67 Mn |
| Mar 31, 2023 | 35.51 Mn |
| Dec 31, 2022 | 39.33 Mn |
| Sep 30, 2022 | 18.69 Mn |
| Jun 30, 2022 | 15.81 Mn |
| Mar 31, 2022 | 21.58 Mn |
| Dec 31, 2021 | 27.18 Mn |
| Mar 31, 2021 | 11.46 Mn |
| Dec 31, 2020 | 13.14 Mn |
| Sep 30, 2020 | 14.66 Mn |
| Jun 30, 2020 | -21.44 Mn |
| Jun 30, 2018 | 687,117.00 |
| Mar 31, 2018 | 1.13 Mn |
| Dec 31, 2017 | 1.37 Mn |
| Jun 30, 2017 | 1.73 Mn |
API Access
Biovie Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=BIVI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "BIVI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=BIVI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();